Related Experiment Video
Updated: Jun 6, 2026
13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
Post mastectomy radiation for large node negative breast cancer: time for a second look
Rimoun Boutrus1, Alphonse G Taghian,
1Radiation Oncology Department, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Critical Reviews in Oncology/Hematology
|December 1, 2010
Summary
This review examines loco-regional failure (LRF) rates in node-negative breast cancer patients with large tumors (≥5cm). It assesses the controversial use of post-mastectomy radiation therapy (PMRT) for this rare patient group.
Area of Science:
- Oncology
- Breast Cancer Research
- Radiation Oncology
Background:
- Node-negative breast cancer patients with large primary tumors (≥5cm) represent a rare clinical subgroup.
- Established management guidelines are lacking for this specific patient population.
- Data on loco-regional failure (LRF) rates and the role of post-mastectomy radiation therapy (PMRT) are scarce and inconsistent.
Purpose of the Study:
- To review existing literature on LRF rates in node-negative, large primary breast tumors (≥5cm).
- To evaluate the evidence supporting the use of PMRT in managing this rare breast cancer cohort.
Main Methods:
- Comprehensive literature search of studies reporting on LRF rates and PMRT in node-negative breast cancer patients with tumors ≥5cm.
- Analysis of reported LRF rates and outcomes associated with or without PMRT.
Main Results:
- Limited data exists on LRF rates in this specific patient group, with significant variability in reported observations.
- The benefit of PMRT in reducing LRF for these patients remains a subject of ongoing debate and requires further investigation.
Conclusions:
- Node-negative breast cancer patients with large primary tumors (≥5cm) require further research to establish optimal management strategies.
- The role and efficacy of PMRT in this rare population need to be clarified through more extensive studies.
